Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) have
significant cardiovascular morbidity and mortality that is in part due to the development of …

Calcific aortic valve disease (CAVD) is the most common heart valve disorder. There is no
medical treatment to prevent and/or promote the regression of CAVD. Hence, it is of foremost …

Staphylococcus aureus sortase A catalyzes the transpeptidation of an LPXTG peptide
acceptor and a glycine-linked peptide donor and has proven to be a powerful tool for site …

An improved enzyme-linked immunosorbent (ELISA) assay using one-step antibody
immobilization has been developed for the detection of human fetuin A (HFA), a specific …

At the early stage of chronic kidney disease (CKD), the systemic mineral metabolism and
bone composition start to change. This alteration is known as chronic kidney disease …

Biomarkers of Vascular Calcification and Mortality in Patien... : Clinical Journal of the
American Society of Nephrology Biomarkers of Vascular Calcification and Mortality in …

Background Patients on haemodialysis (HD) exhibit increased cardiovascular mortality
associated with accelerated vascular calcification (VC). VC is influenced by inhibitors such …

Patients with chronic kidney disease (CKD) are at a particularly high risk for cardiovascular
disease. Vascular calcification (VC) is considered a cardiovascular risk marker, so in CKD …

Calcification is a detrimental process in vascular ageing and in diseases such as
atherosclerosis and arthritis. In particular, small calcium phosphate (CaP) crystal deposits …

Objective Fetuin-A is a novel hepatokine. The number of biologic roles attributed to fetuin-A
has increased exponentially in the past decade. The objective of this review is to discuss the …